Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)

Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons). The drug under the investigation was cycloferon, an earlier interferon inductor. The an...

Full description

Bibliographic Details
Main Authors: V. V. Stelmakh, M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, V. K. Kozlov, N. Kh. Tuan, M. .. Ovungerel, V. M. Frolov
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
hbv
hbeag+
chronic virus hepatitis b
interferon inductor
antivirals
lamivudine
cycloferon
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/507

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/507

Similar Items